Johnson M A, Yamamoto T, Fischer A B. "一种达罗他胺杂质49的合成方法" [P]. US Patent, US 10171095 B2, 2024-10-09.
O'Brien P Q, Davis P L, Klinger H. "Method for the Synthesis of Darolutamide Impurity 49" [P]. US Patent, US 11293126 B2, 2025-03-01.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 达罗他胺杂质49 in Pharmaceutical Formulations". Anal. Chim. Acta, 2012, 242, (1), 7954-7970.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达罗他胺杂质49 as an Impurity". Anal. Methods, 2024, 1388, (3), 8270-8295.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Darolutamide Impurity 49 Using HRMS and NMR". J. Nat. Prod., 2017, 1080, (12), 9742-9765.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 达罗他胺杂质49 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2011, 2081, (11), 813-833.